Digest Network Come funziona
Network
/
Società
Od
Non verificato

Odyssey Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMercato del lavoroSaluteScienza

9 comunicati stampa

Guarda tutti i comunicati
11/11/2025
Odyssey Therapeutics Appoints Dennis Dean, Ph.D., as Executive Vice President, Head of Non-Clinical Development
Fonte
Odyssey Therapeutics, Inc.
Emittente
Business Wire
1.00
0
09/10/2025
Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to Its Board of Directors
Fonte
Odyssey Therapeutics, Inc.
Emittente
Business Wire
1.00
0
10/09/2025
Biotecnologia
Salute
Scienza
Farmaceutica
Mercato del lavoro
Odyssey Therapeutics Announces Oversubscribed $213 Million Series D Financing to Advance Clinical Pipeline for Autoimmune Diseases
Fonte
Odyssey Therapeutics, Inc.
Emittente
Business Wire
1.00
0
08/01/2025
Mercato del lavoro
Associazioni/Professionisti
Salute
Finanza
Farmaceutica
Biotecnologia
Odyssey Therapeutics Appoints Jason Haas as Chief Financial Officer
Fonte
Odyssey Therapeutics, Inc.
Emittente
Business Wire
1.00
0
28/10/2024
Mercato del lavoro
Tecnica
Scienza
Biotecnologia
Salute
Farmaceutica
Information Technology
Odyssey Therapeutics and Terray Therapeutics Enter Strategic Collaboration to Jointly Discover and Develop First-in-Class Transcription Factor Therapies
Fonte
Odyssey Therapeutics, Inc.
Emittente
Business Wire
1.00
0
27/10/2024
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Odyssey Therapeutics to Present New Data on its Clinical-Stage RIPK2 Scaffolding Inhibitor, OD-07656, at the American College of Gastroenterology (ACG) Annual Scientific Meeting 2024
Fonte
Odyssey Therapeutics, Inc.
Emittente
Business Wire
1.00
0
02/10/2024
Mercato del lavoro
Scienza
HIV, AIDS e malattie autoimmuni
Biotecnologia
Sanità
Farmaceutica
Salute
Oncologia
Odyssey Therapeutics Appoints Biopharma Veterans Timothy P. Walbert and Ian F. Smith to its Board of Directors
Fonte
Odyssey Therapeutics, Inc.
Emittente
Business Wire
1.00
0
27/09/2024
Mercato del lavoro
Scienza
Sanità
Farmaceutica
Oncologia
HIV, AIDS e malattie autoimmuni
Biotecnologia
Medicina - Varie
Igiene alimentare
Salute
Odyssey Therapeutics Announces Formation of Scientific Advisory Board
Fonte
Odyssey Therapeutics, Inc.
Emittente
Business Wire
1.00
0
01/08/2024
Salute
Biotecnologia
Scienza
Farmaceutica
Mercato del lavoro
Odyssey Therapeutics Appoints Preeminent Chemist Dr. William Roush as Executive Vice President and Head of Small Molecule Research
Fonte
Odyssey Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0